Dr. Bor-Sheng Ko is currently serving as an associate professor in National Taiwan University College of Medicine (NTUMC), and the director of the Department of Hematological Oncology at the National Taiwan University Cancer Center. Additionally, he works also as an attending physician in the Division of Hematology at the Department of Internal Medicine in the National Taiwan University Hospital (NTUH), and holds the position of director at the Tai-Cheng Cell Therapy Center at National Taiwan University. He obtained his medical degree from the NTUMC in 1995 and completed his clinical training in internal medicine and Hematology/Hematopoietic stem cell transplant (HSCT) fellowship at the NTUH. In 2011, he earned his PhD from the Institute of Clinical Medicine at NTUMC. Dr. Ko spent a year as a visiting research scholar at The University of Texas Health Science Center and MD Anderson Cancer Center in Houston, Texas, USA from 2006 to 2007. He also worked as a joint investigator at the National Health Research Institute in Taiwan from 2010 to 2014. Dr. Ko was elected as the President of Taiwan Society of Blood and Marrow Transplantation from 2019 to 2022. He also served as the president of the Taiwan Society of Pharmacoeconomics and Outcome Research (TaSPOR/ISPOR Taiwan Chapter) from 2018 to 2023, and currently is still the executive director; in addition, he is member of Executive Committee of Asian-Pacific Blood and Marrow Transplantation (APBMT) Group. Currently he is the president of the Hematology Society of Taiwan (HST). His research interests focus on hematopoietic diseases and HSCT, and pharmaco-economics. Recently, he has been involved in establishing databanks, conducting big data analysis, and integrating machine learning and deep learning algorithm into medical practice. Dr. Ko is an active scholar who has published numerous works in reputable international journals within his areas of interest.